Insider filing · TXG
John R Stuelpnagel
Director
profile →
10x Genomics, Inc.
TXG · Healthcare · 28 filings in 24 months
ticker →
John R Stuelpnagel sold $1.2M of 10x Genomics (TXG)
Executed Aug 11, disclosed Aug 13, 2 days later.
Value, as filed
$1.2M
20,000 sh across 2 lots
Executed
Aug 11
the trade date, as filed
Disclosed
Aug 13
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JSJohn R Stuelpnagel (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in 10x Genomics, Inc. (TXG). The largest single filing was $1.2M of TXG (20,000 sh across 3 lots, as filed), executed Sep 3.
The name
TXGHealthcare · 10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John R Stuelpnagel in TXG
TXGSALE
10x Genomics, Inc.
$1.2M20,000 sh across 3 lots
Exec Sep 3
Filed Sep 8 · 7:00 PM ET